The fact that serum NF-kB levels in HT patients administered levothyroxine replacement therapy are higher than those in patients who have not received replacement therapy suggests that autoimmune and inflammatory reactions that cause damage to the thyroid glands continue despite levothyroxine therapy. This evidence concerns the gene NFKB1 and hematocrit.